Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 193
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02960594 | hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse | ||
| NCT00003220 | Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer | ||
| NCT00423826 | Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease | ||
| NCT00020722 | Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer | ||
| NCT04159896 | ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer | ||
| NCT00914147 | Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors | ||
| NCT01609816 | Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma | ||
| NCT00438204 | Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | ||
| NCT00559897 | Zoledronic Acid and Positron Emission Tomography in Treating Patients With Advanced Non-Small Cell Lung Cancer | ||
| NCT00003174 | Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia | ||
| NCT04088786 | Phase I Trial HIPEC With Nal-irinotecan | ||
| NCT00003250 | Fenretinide in Treating Patients With Solid Tumors | ||
| NCT00068653 | Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer | ||
| NCT00002552 | Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma | ||
| NCT00376948 | Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | ||
| NCT00238329 | PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma | ||
| NCT01728259 | First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD | ||
| NCT00717535 | Studying Umbilical Cord Blood From African-American Donors | ||
| NCT00897494 | Identification of Biomarkers for Early Detection of Pancreatic Cancer | ||
| NCT01534143 | High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant | ||
| NCT01251952 | Dose Escalation Trial of Denileukin Diftitox (Ontak) Post Autologous Transplantation | ||
| NCT06107738 | Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma | ||
| NCT01208662 | Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 | ||
| NCT00011973 | Chemotherapy in Treating Patients With Advanced Kidney Cancer | ||
| NCT00004003 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery | ||
| NCT00217581 | Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer | ||
| NCT07118202 | TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma | ||
| NCT02359019 | MK-3475 as Maintenance Therapy in Extensive Stage SCLC | ||
| NCT00004022 | Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma | ||
| NCT05903092 | MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer | ||
| NCT05556473 | F-Tryptophan PET/CT in Human Cancers | ||
| NCT07735819 | Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed With a Glioma | ||
| NCT03453489 | AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm | ||
| NCT00514215 | Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer | ||
| NCT01656304 | Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy | ||
| NCT03683420 | Music in Reducing Distress in Participants with Cancer During Chemotherapy Treatment | ||
| NCT00499694 | Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel | ||
| NCT07743086 | Impact of Duffy-null Associated Neutropenia on Chemotherapy Dosing | ||
| NCT06908629 | Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors | ||
| NCT01643603 | Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies | ||
| NCT00003925 | Combination Chemotherapy In Treating Patients With Advanced Cancer | ||
| NCT00004144 | Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer | ||
| NCT01698658 | Ultrasound Tomography Using SoftVue in Diagnosing Women With Breast Cancer | ||
| NCT05025748 | Ask Questions (ASQ):Implementation of a Communication Intervention | ||
| NCT02145078 | Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer | ||
| NCT07796126 | Sequential Toripalimab and Paclitaxel in Patients With Head and Neck Squamous Cell Cancer (HNSCC) and Poor Performance Status | ||
| NCT02521090 | EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma | ||
| NCT00503841 | Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer | ||
| NCT00872677 | Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors | ||
| NCT00482846 | Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma |
